Publications

A patient consent form for COVID-19 vaccination.

Eligible donors complete this form within 90 calendar days of surgery to claim under the Supporting Living Organ Donors Program.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to re-apply for accreditation every 4 years.

COVID-19 vaccine rollout eligibility declaration form for patients receiving a COVID-19 vaccine.

This checklist includes all the key items health professionals should cover when talking with Aboriginal and Torres Strait Islander patients about bowel screening. These activities do not all need to be carried out by one health professional or all at the same time.

This form is for private hospitals to apply for second-tier default benefits eligibility.

Payments to service providers for submitting forms to the National Cancer Screening Register about the progress of a patient through the bowel screening pathway ended on 31 December 2020.

Clinicians, academics and consumers are invited to express their interest in participating in the MBS ECG Review Committee, which will review changes to MBS ECG items introduced on 1 August 2020 following implementation of recommendations from the MBS Review Taskforce.

Treating physicians use this application form to apply for a patient to access LSDP medication for hereditary tyrosinaemia (type 1) for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for paroxysmal nocturnal haemoglobinuria for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for Fabry disease for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for Pompe disease for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS I for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS II for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS IVA for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS VI for the first time, or after a break.

Treating physicians use this document to certify their patient's meningococcal vaccination status when applying or reapplying for eculizumab through the Life Saving Drugs Program.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to record the Service and/or SCU’s performance against those NAS Measures in which they are responsible for. It must be submitted as part of an application for accreditation.

Stakeholder organisations and other interested parties must use this cover sheet to make a submission to the Review of CGM products provided through the National Diabetes Services Scheme (NDSS).

Suppliers must use this form to make a submission to the Review of CGM products provided through the National Diabetes Services Scheme (NDSS).

This checklist is a guide to help BreastScreen Australia Services and State Coordination Units (SCUs) conduct a self-assessment on the NAS protocols.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to appeal against an accreditation decision of the NQMC.

BreastScreen Australia services and State Coordination Units (SCUs) use this form when intending on commencing a new unit within an existing BSA Service commences, or establishing a new BSA Service.

This online survey is to be used by a Service undergoing an accreditation survey to evaluate the conduct of the accreditation survey.

Data Assessors use this form to record their accreditation survey findings from undertaking a Data Governance and Management Assessment (DGMA) of a BreastScreen Australia Service or State Coordination Unit (SCU).